These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision. Scarpa F, Sabattini S, Marconato L, Capitani O, Morini M, Bettini G. J Am Vet Med Assoc; 2012 May 15; 240(10):1181-7. PubMed ID: 22559107 [Abstract] [Full Text] [Related]
6. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. Kiupel M, Webster JD, Miller RA, Kaneene JB. J Vet Med A Physiol Pathol Clin Med; 2005 Aug 15; 52(6):280-6. PubMed ID: 16050909 [Abstract] [Full Text] [Related]
7. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs. Stanclift RM, Gilson SD. J Am Vet Med Assoc; 2008 Jan 01; 232(1):53-62. PubMed ID: 18167109 [Abstract] [Full Text] [Related]
16. Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005). Rassnick KM, Williams LE, Kristal O, Al-Sarraf R, Baez JL, Zwahlen CH, Dank G. J Am Vet Med Assoc; 2008 Apr 15; 232(8):1200-5. PubMed ID: 18412534 [Abstract] [Full Text] [Related]